US2014296515A1PendingUtilityA1
Alkylamine-substituted dicyanopyridine and amino acid ester prodrugs thereof
Est. expiryJan 29, 2029(~2.5 yrs left)· nominal 20-yr term from priority
Inventors:Alexandros VakalopoulosDaniel MeibomBarbara Albrecht-KüpperKatja ZimmermannJörg KeldenichHans-Georg LerchenPeter NellFrank SüβmeierUrsula Krenz
A61P 9/00A61P 9/04A61P 9/08A61P 9/12A61P 9/10A61P 7/02A61P 3/06A61P 3/10A61P 3/00A61P 3/04C07D 417/12A61K 31/443C07D 417/14A61K 47/64C07D 413/14C07K 5/0202C07K 5/06026C07K 5/06034C07K 5/06147C07K 5/06165C07K 5/06086A61K 31/4427
58
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present application relates to novel 6-alkylamino-substituted dicyanopyridines, to their amino acid ester prodrugs, to processes for their preparation, to their use for the treatment and/or prophylaxis of diseases and to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, preferably for the treatment and/or prevention of cardiovascular disorders.
Claims
exact text as granted — not AI-modified1 - 10 . (canceled)
11 . A compound of formula (XIII):
in which
R 1 represents hydrogen or (C 1 -C 4 )-alkyl,
R 2 represents (C 1 -C 6 )-alkyl, (C 2 -C 4 )-alkenyl, (C 2 -C 4 )-alkynyl or (C 3 -C 7 )-cycloalkyl,
where (C 1 -C 6 )-alkyl may be substituted by 1 to 3 substituents selected independently of one another from the group consisting of fluorine, chlorine, trifluoromethyl, trifluoromethoxy, (C 1 -C 4 )-alkoxy, (C 3 -C 7 )-cycloalkyl, (C 3 -C 7 )-cycloalkoxy, (C 1 -C 4 )-alkylsulfanyl and (C 1 -C 4 )-alkylsulfonyl,
and
where (C 2 -C 4 )-alkenyl and (C 2 -C 4 )-alkynyl may be substituted by 1 or 2 substituents selected independently of one another from the group consisting of fluorine, trifluoromethyl, (C 1 -C 4 )-alkyl, trifluoromethoxy and (C 1 -C 4 )-alkoxy,
and
where (C 3 -C 7 )-cycloalkyl may be substituted by 1 or 2 substituents selected independently of one another from the group consisting of fluorine, chlorine, trifluoromethyl, (C 1 -C 4 )-alkyl, trifluoromethoxy and (C 1 -C 4 )-alkoxy,
or
R 1 and R 2 together with the nitrogen atom to which they are attached form a 4- to 7-membered heterocycle which may contain a further heteroatom from the group consisting of N, O and S,
where the 4- to 7-membered heterocycle may be substituted by 1 or 2 substituents selected independently of one another from the group consisting of fluorine, chlorine, oxo, trifluoromethyl, (C 1 -C 4 )-alkyl, trifluoromethoxy and (C 1 -C 4 )-alkoxy,
R 8 represents hydrogen or the side group of a natural α-amino acid or its homologs or isomers,
R 9 represents hydrogen or methyl,
R 10 represents hydrogen or methyl,
R 11 represents hydrogen or the side group of a natural α-amino acid or its homologs or isomers,
R 12 represents hydrogen or methyl,
R 13A represents hydrogen, (C 1 -C 4 )-alkyl, or an amino protective group,
R 14A represents hydrogen or (C 1 -C 4 )-alkyl, or an amino protective group,
or
R 13A and R 14A together with the nitrogen atom to which they are attached form a 5- or 6-membered heterocycle,
where the 5- or 6-membered heterocycle may be substituted by 1 or 2 substituents independently selected from the group consisting of (C 1 -C 4 )-alkyl, amino, hydroxyl and (C 1 -C 4 )-alkoxy,
or
R 14A together with R 11 and the atoms, to which they are attached, forms a pyrrolidine or piperidine ring,
or a salt thereof.
12 . A compound of formula (XIV):
L 1 represents (C 2 -C 6 )-alkanediyl,
R 1 represents hydrogen or (C 1 -C 4 )-alkyl,
R 2 represents (C 1 -C 6 )-alkyl, (C 2 -C 4 )-alkenyl, (C 2 -C 4 )-alkynyl or (C 3 -C 7 )-cycloalkyl,
where (C 1 -C 6 )-alkyl may be substituted by 1 to 3 substituents selected independently of one another from the group consisting of fluorine, chlorine, trifluoromethyl, trifluoromethoxy, (C 1 -C 4 )-alkoxy, (C 3 -C 7 )-cycloalkyl, (C 3 -C 7 )-cycloalkoxy, (C 1 -C 4 )-alkylsulfanyl and (C 1 -C 4 )-alkylsulfonyl,
and
where (C 2 -C 4 )-alkenyl and (C 2 -C 4 )-alkynyl may be substituted by 1 or 2 substituents selected independently of one another from the group consisting of fluorine, trifluoromethyl, (C 1 -C 4 )-alkyl, trifluoromethoxy and (C 1 -C 4 )-alkoxy,
and
where (C 3 -C 7 )-cycloalkyl may be substituted by 1 or 2 substituents selected independently of one another from the group consisting of fluorine, chlorine, trifluoromethyl, (C 1 -C 4 )-alkyl, trifluoromethoxy and (C 1 -C 4 )-alkoxy,
or
R 1 and R 2 together with the nitrogen atom to which they are attached form a 4- to 7-membered heterocycle which may contain a further heteroatom from the group consisting of N, O and S,
where the 4- to 7-membered heterocycle may be substituted by 1 or 2 substituents selected independently of one another from the group consisting of fluorine, chlorine, oxo, trifluoromethyl, (C 1 -C 4 )-alkyl, trifluoromethoxy and (C 1 -C 4 )-alkoxy,
R 8 represents hydrogen or the side group of a natural α-amino acid or its homologs or isomers,
R 9 represents hydrogen or methyl,
R 10 represents hydrogen or methyl,
R 15A represents hydrogen, (C 1 -C 4 )-alkyl, or an amino protective group,
R 16A represents hydrogen or (C 1 -C 4 )-alkyl, or an amino protective group,
or
R 15A and R 16A together with the nitrogen atom to which they are attached form a 5- or 6-membered heterocycle,
where the 5- or 6-membered heterocycle may be substituted by 1 or 2 substituents independently selected from the group consisting of (C 1 -C 4 )-alkyl, amino, hydroxyl and (C 1 -C 4 )-alkoxy,
or a salt thereof.
13 . A compound of formula (XV):
L 2 represents (C 2 -C 6 )-alkanediyl,
R 1 represents hydrogen or (C 1 -C 4 )-alkyl,
R 2 represents (C 1 -C 6 )-alkyl, (C 2 -C 4 )-alkenyl, (C 2 -C 4 )-alkynyl or (C 3 -C 7 )-cycloalkyl,
where (C 1 -C 6 )-alkyl may be substituted by 1 to 3 substituents selected independently of one another from the group consisting of fluorine, chlorine, trifluoromethyl, trifluoromethoxy, (C 1 -C 4 )-alkoxy, (C 3 -C 7 )-cycloalkyl, (C 3 -C 7 )-cycloalkoxy, (C 1 -C 4 )-alkylsulfanyl and (C 1 -C 4 )-alkylsulfonyl,
and
where (C 2 -C 4 )-alkenyl and (C 2 -C 4 )-alkynyl may be substituted by 1 or 2 substituents selected independently of one another from the group consisting of fluorine, trifluoromethyl, (C 1 -C 4 )-alkyl, trifluoromethoxy and (C 1 -C 4 )-alkoxy,
and
where (C 3 -C 7 )-cycloalkyl may be substituted by 1 or 2 substituents selected independently of one another from the group consisting of fluorine, chlorine, trifluoromethyl, (C 1 -C 4 )-alkyl, trifluoromethoxy and (C 1 -C 4 )-alkoxy,
or
R 1 and R 2 together with the nitrogen atom to which they are attached form a 4- to 7-membered heterocycle which may contain a further heteroatom from the group consisting of N, O and S,
where the 4- to 7-membered heterocycle may be substituted by 1 or 2 substituents selected independently of one another from the group consisting of fluorine, chlorine, oxo, trifluoromethyl, (C 1 -C 4 )-alkyl, trifluoromethoxy and (C 1 -C 4 )-alkoxy,
R 11 represents hydrogen or the side group of a natural α-amino acid or its homologs or isomers,
R 12 represents hydrogen or methyl,
R 13A represents hydrogen, (C 1 -C 4 )-alkyl, or an amino protective group,
R 14A represents hydrogen or (C 1 -C 4 )-alkyl, or an amino protective group,
or
R 13A and R 14A together with the nitrogen atom to which they are attached form a 5- or 6-membered heterocycle,
where the 5- or 6-membered heterocycle may be substituted by 1 or 2 substituents independently selected from the group consisting of (C 1 -C 4 )-alkyl, amino, hydroxyl and (C 1 -C 4 )-alkoxy,
or
R 14A together with R 11 and the atoms, to which they are attached, forms a pyrrolidine or piperidine ring, and
R 19 represents hydrogen or methyl,
or a salt thereof.
14 . A compound of formula (XVI):
L 1 represents (C 2 -C 6 )-alkanediyl,
L 2 represents (C 2 -C 6 )-alkanediyl,
R 1 represents hydrogen or (C 1 -C 4 )-alkyl,
R 2 represents (C 1 -C 6 )-alkyl, (C 2 -C 4 )-alkenyl, (C 2 -C 4 )-alkynyl or (C 3 -C 7 )-cycloalkyl,
where (C 1 -C 6 )-alkyl may be substituted by 1 to 3 substituents selected independently of one another from the group consisting of fluorine, chlorine, trifluoromethyl, trifluoromethoxy, (C 1 -C 4 )-alkoxy, (C 3 -C 7 )-cycloalkyl, (C 3 -C 7 )-cycloalkoxy, (C 1 -C 4 )-alkylsulfanyl and (C 1 -C 4 )-alkylsulfonyl,
and
where (C 2 -C 4 )-alkenyl and (C 2 -C 4 )-alkynyl may be substituted by 1 or 2 substituents selected independently of one another from the group consisting of fluorine, trifluoromethyl, (C 1 -C 4 )-alkyl, trifluoromethoxy and (C 1 -C 4 )-alkoxy,
and
where (C 3 -C 7 )-cycloalkyl may be substituted by 1 or 2 substituents selected independently of one another from the group consisting of fluorine, chlorine, trifluoromethyl, (C 1 -C 4 )-alkyl, trifluoromethoxy and (C 1 -C 4 )-alkoxy,
or
R 1 and R 2 together with the nitrogen atom to which they are attached form a 4- to 7-membered heterocycle which may contain a further heteroatom from the group consisting of N, O and S,
where the 4- to 7-membered heterocycle may be substituted by 1 or 2 substituents selected independently of one another from the group consisting of fluorine, chlorine, oxo, trifluoromethyl, (C 1 -C 4 )-alkyl, trifluoromethoxy and (C 1 -C 4 )-alkoxy,
R 15A represents hydrogen, (C 1 -C 4 )-alkyl, or an amino protective group,
R 16A represents hydrogen or (C 1 -C 4 )-alkyl, or an amino protective group,
or
R 15A and R 16A together with the nitrogen atom to which they are attached form a 5- or 6-membered heterocycle,
where the 5- or 6-membered heterocycle may be substituted by 1 or 2 substituents independently selected from the group consisting of (C 1 -C 4 )-alkyl, amino, hydroxyl and (C 1 -C 4 )-alkoxy,
R 19 represents hydrogen or methyl
or a salt thereof.Join the waitlist — get patent alerts
Track US2014296515A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.